Whilst the world runs from one crisis to another crisis, the M&A market is still keeping a high pace, however, first signs of a slowdown are on the horizon – higher volatility with respect to deals coming and going (the number of deals that A&M is engaged with is a record high, but so is the amount of deals that never start) plus the number of aborted transactions is significantly increasing.

Post-acquisition disputes sometimes arise due to different accounting standards applied. Engaging advisors prior to executing a purchase agreement is helpful to mitigate the risk of such disputes. In this edition of Raising the Bar, we discuss the situations when conflicting standards may arise and examples of disputes that might occur.

Kathleen King shares more about the Work Opportunity Tax Credit (WOTC) capability and the most common questions she receives from clients.

What investors expect out of healthcare in the rest of 2022

As global challenges continue, asset-light pharmaceutical companies will remain under increased pressure for the rest of 2022 and beyond. How can asset-light companies create value in a disrupted market? A&M shares 5-value levers for asset-light pharmaceutical businesses.

Managing Director Vadim Tsysin joined Morgan & Westfield on their podcast, M&A Talk, to discuss the purpose of due diligence, how you should prepare, and what happens when issues are uncovered.

What are the latest SEC climate rules and what do they mean for energy, commodities and other sectors? Learn from this HC Insider podcast featuring Managing Director Julie McLaughlin.

Take a closer look at the practical and forensic aspects of how the imaging process works and consider the implications of the new form order.

Multinational companies operating in Brazil must evaluate their current transfer pricing models to determine how they will adapt to the new transfer pricing system proposed by the Brazilian tax authority.

We are aware of HMRC sending letters to LLPs regarding the salaried member rules. The salaried member rules became effective from 6 April 2014, as anti-avoidance legislation which HMRC are now seeking to review, along with other measures introduced at the same time. 

Will this be the year that private equity firms get back into the oil and gas game?

Black Swan Siblings: How Should Private Equity Investors in Manufacturing Companies Respond?

The current M&A boom is showing no signs of slowing down and it’s easy to forget that two years ago when Covid-19 first hit, M&A activity across several sectors came to an abrupt end (well, pause).

CFOs are feeling pressure from higher valuations and an unstable economy. In order to succeed, they must stay focused on 3 key priorities. Read the full article to learn more.